Orthofix International traded at $8.14 this Friday November 6th, decreasing $0.78 or 8.74 percent since the previous trading session. Looking back, over the last four weeks, Orthofix International lost 13.50 percent. Over the last 12 months, its price fell by 44.55 percent. Looking ahead, we forecast Orthofix International to be priced at 8.88 by the end of this quarter and at 8.32 in one year, according to Trading Economics global macro models projections and analysts expectations.
Orthofix Medical Inc., formerly Orthofix International N.V., is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim. The Biologics products include AlloQuent Structural Allografts, Trinity ELITE, Trinity Evolution and VersaShield. The Extremity Fixation products include Fixator, Eight-Plate Guided Growth System and Contours VPS Volar Plating System III. The Spine Fixation products include Hallmark Anterior Cervical Plate System, Ascent LE Posterior Occipital Cervico-Thoracic (POCT) System, Firebird Deformity Correction System, Phoenix Minimally Invasive Spinal Fixation System, LONESTAR Cervical Stand Alone (CSA), SKYHAWK Lateral Interbody Fusion System & Lateral Plate System and CENTURION POCT System.